Neste Publishes 2027 Financial Calendar While Deprioritizing Bioplastics — Record Fuel Margins Mask Chemicals Retreat

HELSINKI — Neste Corporation (Nasdaq Helsinki: NESTE) has published its 2027 financial reporting calendar, providing transparency for investors as the company navigates a pivotal strategic shift. The world’s leading renewable diesel and sustainable aviation fuel (SAF) producer will report full-year 2026 results on 10 February 2027, with interim reports scheduled for 28 April, 22 July, and 28 October 2027. The Annual General Meeting is set for 23 March 2027.

The schedule arrives against a backdrop of extraordinary financial performance in renewable fuels — and a simultaneous retreat from the bioplastics and circular chemicals space that once featured prominently in Neste’s growth narrative.

Record Fuel Margins, But Cracks in the Growth Story

Neste’s half-year 2026 results, released 24 July, were striking on the surface. Group comparable EBITDA reached EUR 2,064 million for January–June (versus EUR 551 million in 2025), driven primarily by Renewable Products’ all-time high comparable EBITDA of EUR 1,292 million. The second quarter alone delivered EUR 1,203 million in comparable EBITDA, with Renewable Products’ sales margin hitting a record USD 1,223 per ton — more than triple the USD 361/ton seen in Q2 2025.

CEO Heikki Malinen attributed the surge to “exceptional market environment” driven by Middle East conflict dynamics, favorable regulatory decisions (including Germany’s RED III adoption adding ~1.5 million tonnes of renewable diesel demand), and strong RIN prices in the US. The performance improvement program contributed EUR 118 million in Q2 alone, with a cumulative EUR 594 million run-rate improvement against the 2024 baseline.

Yet beneath these headline numbers lies a more sobering reality for the bioplastics sector.

The Bioplastics Retreat

In February 2026, Neste announced it would “streamline its renewable and circular polymers and chemicals activities, focusing on renewable fuels.” The company explicitly stated it would “scale down investments” in development activities including Power-to-X, and CEO Malinen acknowledged on an analyst call that Neste must “deprioritize” sustainable chemicals at present.

The rationale was blunt: “We are now at a time in the company where we really have to focus on what really moves the needle.” Malinen cited a lack of clear regulatory framework, limited mandates, and largely voluntary demand for renewable chemicals. “And therefore, we have to deprioritize.”

This represents a significant pivot. As recently as 2023, Neste was investing EUR 111 million in a 150,000 tonne-per-year liquefied waste plastics upgrading unit at Porvoo — part of a broader EUR 135 million EU Innovation Fund-backed project targeting 400,000 tonnes/year of waste plastics upgrading capacity by 2030. The upgrader was designed to process liquefied raw materials into drop-in feedstock for plastics and chemicals production, supporting Neste’s stated goal of processing more than 1 million tonnes/year of post-consumer waste plastics by 2030.

That timeline is now uncertain. The company confirmed it will continue with the Porvoo upgrading unit but offered no updated completion date. The Rotterdam refinery expansion — which would add 1.3 million tonnes/year of renewable capacity (including 1.2 million tonnes SAF capability) — has been delayed from 2026 to 2027, with costs ballooning from EUR 1.9 billion to EUR 2.5 billion.

Financial Figures: A Mixed Picture

Strengths:

• Leverage ratio at 29.9% (end of June 2026), comfortably below the 40% target
• Free cash flow generation improving, though Q2 was impacted by EUR 842 million working capital build for maintenance turnarounds
• Renewable Products sales volumes exceeding 1 million tonnes in Q2 2026
• Cost discipline delivering ahead of the EUR 350 million EBITDA run-rate improvement target (EUR 250 million from operational costs)

Concerns:

• 2024 was a disastrous year: Group EBITDA collapsed to EUR 1.25 billion from EUR 3.46 billion in 2023; net loss of EUR 95 million versus EUR 1.44 billion profit in 2023
• Renewable sales margin imploded: From USD 863/ton (2023) to USD 377/ton (2024) — a 56% drop — before rebounding to USD 1,223/ton in Q2 2026 on exceptional market conditions
• Global overcapacity in renewable fuels: “Numerous new competitors and increased capacity entered the markets during 2024”
• Capex intensity: EUR 1.2 billion full-year 2026 capex (excluding M&A) with three major turnarounds scheduled in H2 2026
• Workforce reduction: ~600 redundancies (450 in Finland) as part of efficiency drive

Assessment: Good for Fuels, Concerning for Circularity

The bull case: Neste is executing superbly on its core renewable fuels business. The regulatory tailwinds (RED III, US mandates, RIN prices) are real and durable. The Rotterdam expansion, despite delays and cost overruns, will create the world’s largest renewable diesel/SAF refinery. The balance sheet is strengthening, and the company is generating substantial cash from its advantaged feedstock portfolio (90% waste and residue inputs).

The bear case for bioplastics: Neste’s retreat from chemicals and polymers is a strategic admission that the bioplastics business model — without regulatory mandates equivalent to transport fuel blending obligations — cannot compete for capital against the high-return fuels business. The economics of chemical recycling and renewable polymers remain challenged by:

• Voluntary demand only (no blending mandates)
• Higher processing costs vs. fossil naphtha
• Immature collection/sorting infrastructure for waste plastics
• Long payback periods on capital-intensive upgrading units

For the bioplastics industry, Neste’s deprioritization removes a critical scale player and potential offtake partner. The 400,000 tonne/year upgrading target (and 1 million tonne/year 2030 ambition) represented one of the few credible pathways to industrial-scale circular feedstock supply in Europe. That capacity is now “on the backburner for at least the next two years.”

View on Financial Health

Rating: B+ for fuels execution; C for circularity commitment

Neste’s financials are undeniably strong in the current market structure. The company is a beneficiary of policy-driven demand for renewable diesel and SAF, with a uniquely integrated global refinery network and feedstock supply chain. The EUR 19.0 billion 2025 revenue base provides resilience.

However, the financial engineering masks a strategic narrowing. The EUR 350 million improvement program is largely cost-cutting (600 jobs, delayed investments) rather than growth investment. The Rotterdam overrun (EUR +600 million) and delay absorb capital that might have funded the polymers pivot. The 2024 collapse (EBITDA -64%, net loss) revealed the fragility of renewable fuel margins when policy support wavers or overcapacity emerges.

For bioplastics stakeholders, the message is clear: Neste will remain a dominant renewable fuels player, but it will not be the circular chemicals champion the industry hoped for — at least not in this decade. The 6.8 million tonne capacity target by 2027 is almost entirely fuels-oriented.

The 2027 financial calendar is a routine governance milestone. The real story is what Neste isn’t scheduling: meaningful capital allocation to bioplastics.

Neste’s 2027 Financial Reporting Calendar:

• Financial Statements 2026: 10 February 2027
• Interim Report Q1 2027: 28 April 2027
• Half-Year Report H1 2027: 22 July 2027
• Interim Report Q3 2027: 28 October 2027
• Annual Report 2026: By 2 March 2027
• AGM 2027: 23 March 2027

Source: Neste Corporation Stock Exchange Release, 18 August 2026; Half-Year Financial Report January–June 2026, 24 July 2026; Borderless/Chemweek reporting, February 2026.